Ritsuko Komaki
Komaki, Ritsuko.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 61832369 (Personal)
Permalink: http://viaf.org/viaf/61832369
Preferred Forms
-
200 _ |
‡a
Komaki
‡b
Ritsuko
-
100 1 _
‡a
Komaki, Ritsuko
-
100 1 _ ‡a Komaki, Ritsuko
-
100 1 _
‡a
Komaki, Ritsuko
-
100 1 _ ‡a Komaki, Ritsuko
-
100 1 _ ‡a Komaki, Ritsuko
-
100 1 _
‡a
Komaki, Ritsuko
-
100 1 _
‡a
Komaki, Ritsuko
-
100 1 _
‡a
Komaki, Ritsuko
-
100 1 _ ‡a Komaki, Ritsuko.
-
100 0 _
‡a
Ritsuko Komaki
4xx's: Alternate Name Forms (6)
Works
| Title | Sources |
|---|---|
| Intensity-modulated radiation therapy : clinical evidence and techniques |
|
| Lung cancer |
|
| Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology |
|
| Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy |
|
| Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial |
|
| Predictors of postoperative complications after trimodality therapy for esophageal cancer |
|
| Preoperative Chemo-Radiation-Induced Ulceration in Patients with Esophageal Cancer: A Confounding Factor in Tumor Response Assessment in Integrated Computed Tomographic-Positron Emission Tomographic Imaging |
|
| Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity |
|
| Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-di |
|
| Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review |
|
| Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest |
|
| Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer |
|
| Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT) |
|
| Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure |
|
| Quantification of regional ventilation from treatment planning CT. |
|
| Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer |
|
| Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challenge |
|
| Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer |
|
| Radiation pneumonitis: local dose versus [18F]-fluorodeoxyglucose uptake response in irradiated lung. |
|
| Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. |
|
| Recursive Partitioning Analysis Identifies Pretreatment Risk Groups for the Utility of Induction Chemotherapy Before Definitive Chemoradiation Therapy in Esophageal Cancer |
|
| Reduction of pulmonary compliance found with high-resolution computed tomography in irradiated mice. |
|
| Reply to v.R. Bhatt et Al and m.C. Chamberlain |
|
| Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. |
|
| Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy |
|
| Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy |
|
| Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma |
|
| Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cance |
|
| Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy |
|
| Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto |
|
| Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". |
|
| Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity |
|
| Superior sulcus tumors with vertebral body involvement: a multimodality approach |
|
| Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy |
|
| Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma |
|
| Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases |
|
| Target definition and contouring in carcinoma of the lung and esophagus. |
|
| Target delineation and treatment planning in breast conserving therapy. |
|
| Technical Advances of Radiation Therapy for Thymic Malignancies |
|
